ArticleCancers2026

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC).

Roni Gillis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.